Sucheta Dalal :Patients may survive diseases but will be killed by drug pricing of Big Pharma
Sucheta Dalal

Click here for FREE MEMBERSHIP to Moneylife Foundation which entitles you to:
• Access to information on investment issues

• Invitations to attend free workshops on financial literacy
• Grievance redressal

 

MoneyLife
You are here: Home » What's New » Patients may survive diseases, but will be killed by drug pricing of Big Pharma
                       Previous           Next

Patients may survive diseases, but will be killed by drug pricing of Big Pharma  

October 7, 2014

Treatments like cancer cost so much money that the patient may often lose every asset he has built over the course of his or her life. Are these prices justified and reasonable? A new report by CBS 60 Minutes asks

 

Moneylife Digital Team

 

The latest 60 Minutes episode on the CBS network takes on extortionist pricing of big-pharma for medicines such as for cancer. Not only does the show attack the exorbitant pricing of the drugs, it also dissects the practise that guides prescriptions by doctors and clinics for patients suffering from Cancer.

 

To read more on this click here


-- Sucheta Dalal